Overview
Disorder of neutral amino acid transport (Orphanet code 308451) is a broad category encompassing rare inherited metabolic conditions in which the body's ability to transport neutral amino acids across cell membranes is impaired. The best-known condition in this group is Hartnup disease (also called Hartnup disorder), which results from defective transport of neutral amino acids (such as tryptophan, alanine, serine, threonine, valine, leucine, isoleucine, and phenylalanine) in the intestinal epithelium and renal proximal tubules. This leads to excessive urinary excretion of these amino acids (aminoaciduria) and impaired intestinal absorption. Because tryptophan is a precursor to niacin (vitamin B3), affected individuals may develop pellagra-like symptoms including a photosensitive skin rash, cerebellar ataxia, and neuropsychiatric manifestations such as emotional instability, cognitive difficulties, and psychotic episodes. Other body systems that may be affected include the gastrointestinal tract, with intermittent diarrhea reported in some patients. The clinical presentation is highly variable. Many individuals identified through newborn screening remain asymptomatic throughout life, while others develop episodic symptoms triggered by poor nutrition, illness, stress, or sun exposure. Symptoms typically first appear in childhood but can manifest at any age. The severity of clinical features often correlates with dietary niacin intake and overall nutritional status. Treatment is primarily supportive and nutritional. Oral nicotinamide (niacinamide) supplementation is the mainstay of therapy and can effectively prevent or ameliorate symptoms. A high-protein diet is recommended to compensate for impaired amino acid absorption. Sun protection is advised to prevent photosensitive skin reactions. With appropriate management, the prognosis is generally favorable, and many patients experience improvement or resolution of symptoms with age. Genetic counseling is recommended for affected families.
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Disorder of neutral amino acid transport.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Disorder of neutral amino acid transport at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Disorder of neutral amino acid transport.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Disorder of neutral amino acid transport.
Community
No community posts yet. Be the first to share your experience with Disorder of neutral amino acid transport.
Start the conversation →Latest news about Disorder of neutral amino acid transport
No recent news articles for Disorder of neutral amino acid transport.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Disorder of neutral amino acid transport
What is Disorder of neutral amino acid transport?
Disorder of neutral amino acid transport (Orphanet code 308451) is a broad category encompassing rare inherited metabolic conditions in which the body's ability to transport neutral amino acids across cell membranes is impaired. The best-known condition in this group is Hartnup disease (also called Hartnup disorder), which results from defective transport of neutral amino acids (such as tryptophan, alanine, serine, threonine, valine, leucine, isoleucine, and phenylalanine) in the intestinal epithelium and renal proximal tubules. This leads to excessive urinary excretion of these amino acids (a
How is Disorder of neutral amino acid transport inherited?
Disorder of neutral amino acid transport follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.